SLC6A14 expression was shown to be an independent prognosis factor for OS and DSS of PC patients, while LAMC2 expression was found to be an independent predictive factor for DSS and PFI, according to multivariate analysis. Here, SLC6A14 is linked to pachyonychia congenita.